This report contains market size and forecasts of Engineered T Cells in Global, including the following market information:
- Global Engineered T Cells Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Engineered T Cells market was valued at 270.8 million in 2021 and is projected to reach US$ 1308.3 million by 2028, at a CAGR of 25.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tumor Infiltrating Lymphocytes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Engineered T Cells include Autolus Limited, Bellicum Pharmaceuticals, Cells Medica, Elli Lilly and Company, Gilead Sciences, Juno Therapeutics, Novartis, Oxford Biomedica and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Engineered T Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Engineered T Cells Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Engineered T Cells Market Segment Percentages, by Type, 2021 (%)
- Tumor Infiltrating Lymphocytes
- T Cell Receptor {TCR}
- Chimeric Antigen Receptor(CAR)
Global Engineered T Cells Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Engineered T Cells Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Cancer Research Centers
- Clinics
Global Engineered T Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Engineered T Cells Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Engineered T Cells revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Engineered T Cells revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Autolus Limited
- Bellicum Pharmaceuticals
- Cells Medica
- Elli Lilly and Company
- Gilead Sciences
- Juno Therapeutics
- Novartis
- Oxford Biomedica
- Pfizer
- Precision Bioscience
- Redmile Group
- Seeking Alpha
- Unum Therapeutics
